Skip to main content
. Author manuscript; available in PMC: 2011 Jan 11.
Published in final edited form as: Exp Brain Res. 2008 Dec 2;193(4):555–563. doi: 10.1007/s00221-008-1658-4

Table 3.

Subject characteristics at T3 (after training) where all % values represent % maximum stimulator output unless stated otherwise. Values represent means ± standard deviation.

Drug arm RMT AMT Sensory
threshold
SICI/ICF LICI SAI
TS
Intensity
TS
Amplitude
TS
Intensity
TS
Amplitude
TS
Intensity
TS
Amplitude
Lorazepam 40.4
± 7.7 %
30.6
± 5.3 %
0.22
± 0.06 mA
50.6
± 8.8 %
0.85
± 0.71 mV
50.7
± 8.6 %
0.82
± 0.70 mV
51.4
± 8.2 %
0.66
± 0.50 mV
Zolpidem 40.6
± 5.0 %
30.0
± 5.6 %
0.18
± 0.04 mA
50.3
± 7.4 %
0.78
± 0.36 mV
49.4
± 8.4 %
0.72
± 0.30 mV
49.9
± 7.9 %
0.66
± 0.33 mV